MedPath

MORPHINE SULFATE INJECTION, USP

MORPHINE SULFATE INJECTION, USP

Approved
DIN Number

02488620

Drug Class

Human

Market Date

N/A

Company
HC

fresenius kabi canada ltd

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02488620
AIG Number0104545008
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic (CDSA I)
A
ATC Code
N02AA01 MORPHINE
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous ,  Intramuscular ,  Intravenous
AHFS Classification28:08.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

MORPHINE SULFATEActive
Strength: 2 MG / 1 ML
Monograph: MORPHINE SULFATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.